Insecticidal toxin useless without 'friendly' bacteria accomplices
The toxin produced by the bacterium Bacillus thuringiensis (Bt) is a popular insecticide used to control pest moths and butterflies, and in some GM pest-proof crops. In a study published in the open access journal BMC Biology, researchers show that its effectiveness against a number of susceptible Lepidopteran species depends on the presence of the normally "friendly" bacteria that colonise their guts. Without these bacteria, the Bt toxin can become impotent in some species. A team of researchers from the University of Wisconsin studied the effects of wiping out the commensal gut bacteria using antibiotics in six moth and butterfly species. In five of these species, the antibiotic treatment protected the insects against the lethal effects of the toxin, and in four of the five species, replacing the gut bacteria caused the toxin to become effective again. Graduate student Nichole Broderick said, "Our results suggest that Bt may kill some insects by causing otherwise benign gut bacteria to exert pathogenic effects. If the insects don't have these bacteria present, the toxin may be ineffective".
According to the authors, "We've shown that larval enteric bacteria affect susceptibility to Bt, and the extent of this impact varies across butterfly and moth species. This does not exclude other factors, including the insect host, B. thuringiensis strain, and environmental conditions. In some cases these factors may interact, for example, host diet can alter the composition of enteric bacteria".
They conclude, "From a pest management perspective, the ability of a non-specific enteric bacterium to restore B. thuringiensis-induced mortality of some Lepidopteran species may provide opportunities for increasing susceptibility or preventing resistance".
Source: BioMed Central
Related
- GM crops protect neighbors from pestsThu, 18 Sep 2008, 14:56:46 EDT
- Friendly bacteria reduce hospital infectionsWed, 5 Nov 2008, 19:22:47 EST
- Test of bacteria toxin delivery system could pave way for new antibiotic drugsMon, 16 Jun 2008, 11:42:29 EDT
- NYU scientists discover dangerous new method for bacterial toxin transferTue, 6 Jan 2009, 16:15:36 EST
- In shaping our immune systems, some 'friendly' bacteria may play inordinate roleThu, 15 Oct 2009, 12:41:35 EDT
Other sources
- Insecticidal toxin useless without 'friendly' bacteria accomplicesfrom Science CentricWed, 4 Mar 2009, 14:35:22 EST
- Insecticidal toxin useless without 'friendly' bacteria accomplicesfrom PhysorgWed, 4 Mar 2009, 8:21:06 EST
Latest Science Newsletter
Get the latest and most popular science news articles of the week in your Inbox!Learn more about
Popular science news articles
- Scientists visualize how bacteria talk to one another
- Findings show nanomedicine promising for treating spinal cord injuries
- Lasers put a shine on metals
- Deep creep means milder, more frequent earthquakes along Southern California's San Jacinto fault
- Developmental delay could stem from nicotinic receptor deletion
- African desert rift confirmed as new ocean in the making
- Why nice guys usually get the girls
- Does green tea prevent cancer? Evidence continues to brew, but questions remain
- Digital 'plaster' for monitoring vital signs undergoes first clinical trials
- Higher carotid arterial stenting rates associated with poorer clinical outcomes
- African desert rift confirmed as new ocean in the making
- 1 shot of gene therapy and children with congenital blindness can now see
- Scientists discover influenza's Achilles heel: Antioxidants
- Cleanliness is next to godliness: New research shows clean smells promote moral behavior
- Super typhoon Lupit heading west in the Philippine Sea
No popular news yet
- African desert rift confirmed as new ocean in the making
- Common plants can eliminate indoor air pollutants
- Study reveals a 'missing link' in immune response to disease
- Reduction in glycotoxins from heat-processing of foods reduces risk of chronic disease
- Digital 'plaster' for monitoring vital signs undergoes first clinical trials